Large‐scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

Cited by (254)

Items 201–254 of 254

  1. The influence of orphenadrine HCl in overdose alone and in combination with droperidol on respiration and circulation in the rat.
    Bart Sangster, G Nieuwland, A. N. E. Zimmerman, Ad N. P. van Heijst · 1979 · PubMed
  2. Neurodegenerative Biomarkers in Healthy Elderly - with special reference to the preclinical pattern of biological and cognitive markers for Alzheimer’s disease
    Erik Stomrud · 2009 · Lund University Publications (Lund University)
  3. Current Awareness
    2001 · International Journal of Geriatric Psychiatry
  4. Type 2 Diabetes Mellitus Control during COVID 19 Pandemic in Qatar 2020: A Retrospective Data Analysis
    Hamzeh Yousef khmour, Yosaf Al-Rabeei, Nashwan Zainal Deen, Salma Elnour, Khalid Al-Karbi, Mostafa Hamdy Rashed, Muneera Al-Muhannadi, Mansour Elmahdi, Hanan Al Shamari, Mustfa Abdelhamied abugesiesa et al. · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  5. Cerebrospinal Fluid Based Diagnosis in Alzheimer’s Disease
    Inga Zerr, Lisa Kaerst, Joanna Gawinecka, Daniela Varges · 2011 · InTech eBooks
  6. Translational Research in Alzheimer’s Disease for Development of Antibody-Based Therapeutics
    Eric Yuen, Enchi Liu, Gene G. Kinney · 2012 · Springer eBooks
  7. Cerebrospinal Fluid Tau and Phosphotau As Biomarkers in Alzheimer's Disease Diagnosis
    Nahid Ahmadian, Mahnaz Talebi, Javad Mahmoudi, Saeed Sadig Etegad, Alireza Aghili · 2019 · Basic and Clinical Neuroscience Journal
  8. CSF Biomarkers
    Alessandra Piccini · 2010 · The Open Nuclear Medicine Journal
  9. Sleep Patterns and Academic Performance among Medicine and Pharm D students in Almaarefa University 2018-2019
    Mashel A. Alzunidi, Jawaher A Alowayyid, Rabab A Benhadi, Habiba H. Farouk, Malak H. Alshammari, Asmaa S. Sultan, Rana A. Almojil, Alanoud A. Alshathri, Noor N. Alsalman, Shahad S. Alshaya et al. · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  10. Prevalence of overt and subclinical hypothyroidism during pregnancy in antenatal care - cross-sectional study, Jeddah, Saudi Arabia
    Lubna M. Zahrani, Mada I. Abdulhaq, Taghreed M. Shams, Fayssal Mostafa Farahat · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  11. Prevalence of Generalized Anxiety Disorder among Medical Residents in Hamad Medical Corporation in 2020
    Mohamed Abdullah Jummah Hnish, Nashwan Zainal Deen, Salma Snoussi, Hind Mohamad, Mohamed Abdalla, Issameldin Abdelbagi · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  12. Mild cognitive impairment: biological diagnostic markers for early stages of Alzheimer's disease
    Katsuya Urakami · 2006 · Psychogeriatrics
  13. Importance of vascular aspects in Alzheimer's disease
    Hiroyuki Arai · 2006 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  14. Biological Markers in Alzheimer's Disease
    Ramon R. Diaz-Arrastia, Fred Baskin · 2003 · Humana Press eBooks
  15. Biomarkers and Surrogate Markers in Drug Development
    Neal R. Cutler, John J. Sramek, Michael F Murphy, Henry Riordan, P. R. Bieck, Angelico Carta · 2010 · Wiley eBooks
  16. Brain sterol metabolism : modulating Alzheimer’s disease
    Tim Vanmierlo · 2010 · Research Publications (Maastricht University)
  17. Disease‐Specific Cerebrospinal Fluid Investigations
    Florian Deisenhammer, Robert Egg, Gavin Giovannoni, Bernhard Hemmer, Axel Petzold, Finn Thorup Sellebjerg, Charlotte Elisabeth Teunissen, Hayrettin Tumani · 2011 · Wiley eBooks
  18. Identification of Novel Fluid Biomarkers for Alzheimer's Disease
    Rebecca Craig‐Schapiro · 2012 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  19. Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis
    Christine Bétard, Filippo Martinelli Boneschi, Paulo Caramelli · 2010 · Wiley eBooks
  20. Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer’s Disease
    Andreas Papassotiropoulos, Alessia S. Maddalena, Danielle Christiane Gretener, Roger M. Nitsch, Christoph Höck · 2004 · Springer eBooks
  21. Studies on diagnostic markers for Alzheimer's disease
    Katsuya Urakami, Miyako Taniguchi, Masashi Inoue, Kenji Wada‐Isoe, Yosuke Wakutani, Kenji Nakashima · 2005 · Psychogeriatrics
  22. Combinational Western and oriental medicine therapies for geriatric syndrome
    K Iwasaki, Takashi Seki, Hiroyuki Arai, H. Sasaki · 2005 · Geriatrics and gerontology international/Geriatrics & gerontology international
  23. PMD2 A META-ANALYSIS OF BIOMARKERS AND DIAGNOSTIC IMAGING IN ALZHEIMER'S DISEASE
    Sean D. Sullivan, Lisa M. Bloudek, David Eldon Spackman, Michael Blankenburg · 2011 · Value in Health
  24. The 1st Taiwan-Japan Symposium on Dementias
    Ching‐Kuan Liu · 2006
  25. Tau Protein, Ischemic Injury and Vascular Dementia
    Elizabeta B. Mukaetova‐Ladinska, Mosi Li, Raj N. Kalaria · 2015 · Future Neurology
  26. Diagnosis and biomarkers
    Dag Aarsland, Jeffrey L. Cummings, Daniel A. Weintraub, К. Ray Chaudhuri · 2013 · Cambridge University Press eBooks
  27. Current strategies in the discovery of small-molecule biomarkers for
    Luke Whiley · 2011
  28. [Biological diagnositic markers for Alzheimer's disease].
    Masatoshi Takeda, Toshihisa Tanaka, Takashi Kudo, Masayasu Okouchi, Kojin Kamino, Masatsugu Tagami · 2005 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  29. [Alzheimer's disease should be treated as a vascular disease].
    Katsuya Urakami · 2006 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  30. Diagnosis and biomarkers: CSF
    Brit Mollenhauer, Henrik Zetterberg · 2013 · Cambridge University Press eBooks
  31. Detection and conformational characterization of misfolded proteins in neurodegenerative diseases
    Olga A. Morozova · 2016 · Library, Museums and Press - UDSpace (University of Delaware)
  32. Amyloid beta and tau proteins in Alzheimer’s disease and Down syndrome
    Pankaj D Mehta · 2018 · CRC Press eBooks
  33. 한국의 알츠하이머병 환자에서 아세틸콜린 에스터레이스 억제제의 뇌척수액 베타아밀로이드 1-42 분획과 인산화타우단백 농도에 미치는 효과
    이은희, 윤영철, 박광열, 민주홍, 권오상, 이현옥, 홍현종 · 2008 · Journal of the Korean Neurological Association
  34. Method and Clinical Validation of Biomarkers for Neurodegenerative Diseases
    Ulf Andréasson, Kaj Blennow, Henrik Zetterberg · 2021 · Neuromethods
  35. Differential Localization of Hic-5 and Paxillin in the Brain of Alzheimer's Disease Subjects
    John Caltagarone · 2008 · D-Scholarship@Pitt (University of Pittsburgh)
  36. References
    2005 · Elsevier eBooks
  37. Demenz
    Jens Wiltfang, Sarah Trost, Harald-Jürgen Hampel · 2016 · Springer eBooks
  38. Demenz
    Harald Juergen Hampel, Johannes Pantel · 2011 · Springer eBooks
  39. Tauopathies
    John Cornelis Van Swieten · 2005 · Neurological disease and therapy
  40. Demenz
    Harald Juergen Hampel, Katharina Bürger, Tanja Fuchsberger · 2006 · Springer eBooks
  41. Laborchemische Diagnostik
    Brigitta Bondy · 2006 · Springer eBooks
  42. The Quality of Life among the Adult Population during COVID-19 in Saudi Arabia
    Reda Abdelmoaty Goweda, Turki Nizar Hammad, Zakaria Ali Khan, Ahmed Ali Alghamdi, Abdulaziz Otaywi Alyazidi, Abdullah G. Alharbi, Khalid Abdulrahman Almalki, Mohammed Abdullah Alzahrani, Ahmad Abdulaziz Alzubaidi · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  43. Documentation of paediatric observations in an urgent care setting; a Quality Improvement Project
    Rahma Yusuf Ali · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  44. Contrast-Induced Nephropathy among adults after administration of intravenous material in the Emergency department at King Abdul-Aziz university hospital
    Afaf S. Al-Saiari, Samiyah Alsaedi, Esraa Alzahran, Latifah Kutbi, Bothainah Abed A Alsahafi, Ghoson ghonem alharbi, Mostafa Abdelsalam, Abdullah A. Bakhsh · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  45. Rare presentation of lower limb weakness, a case report
    Hamzeh Yousef khmour, Salma el Nour, Mansour Elmahdi · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  46. Insulin Resistance Related to Metabolic Syndrome
    Hanan Taha Al Shamery, Neelufur Sulaiman Sait · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  47. Clinical Audit Report on Adherence to Imaging Guidelines for Patients with Acute Low Back Pain in Airport Health Centre
    Hanan Taha Al Shamery, Wesam Abouamer, Neelufur Sulaiman Sait · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
  48. Identifying genetic factors that increase cognitive reserve: A theoretical approach
    Daniel Neidigk, Allie Linkous, Rodney P. Guttmann · 2023 · Research Ideas and Outcomes
  49. Advances in fluid-based biomarkers
    Henrik Zetterberg · 2025 · Elsevier eBooks
  50. Neuroblastoma
    Ivan A. Ross · 2025 · Springer eBooks
  51. Capillary Plasma GFAP and NfL Track In Vivo Tauopathy Progression in PS19 Mice
    Anna Harima, Natsumi Kobayashi, Sharma Sanjiv, Takahiko Tokuda, Makoto Higuchi, Kaori Tsukakoshi, Tomoaki Murakami · 2026 · Research Square
  52. Recherche d'un profil protéique corrélé aux encéphalopathies spongiformes subaigües transmissibles (ESST) : analyses en spectrométrie de masse SELDI-TOF
    Isabelle Batxelli · 2010
  53. Prévention du phénomène de nucléation et de la propagation des tauopathies par immunothérapie passive utilisant un anticorps ciblant une région centrale de la protéine tau
    Marie Albert · 2018 · theses.fr (ABES)
  54. Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management
    Isabel Estragués-Gázquez, José Contador, Leidy Dayana Martinez, Aida Fernández‐Lebrero, Greta García‐Escobar, Irene Navalpotro‐Gómez, Oriol Grau‐Rivera, Gianmarco Iaccarino, Rosa María Manero-Borràs, Paula Ortiz‐Romero et al. · 2026 · JAMA Neurology